Items without sitelinks

From determinar.ia.br - Determine suas informações

Showing below up to 50 results in range #5,151 to #5,200.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Injury or harm in therapeutic use of anticholinergics or antimuscarinics (Q107670)
  2. Injury or harm in therapeutic use of theophylline (Q107669)
  3. Injury or harm in therapeutic use of theobromine (Q107668)
  4. Injury or harm in therapeutic use of salbutamol (Q107667)
  5. Injury or harm in therapeutic use of aminophylline (Q107666)
  6. Injury or harm in therapeutic use of ergot alkaloids (Q107665)
  7. Injury or harm in therapeutic use of metaraminol (Q107664)
  8. Injury or harm in therapeutic use of cholinergics (Q107663)
  9. Injury or harm in therapeutic use of oral rehydration salts (Q107662)
  10. Injury or harm in therapeutic use of acetazolamide (Q107661)
  11. Injury or harm in therapeutic use of vitamin D group (Q107660)
  12. Injury or harm in therapeutic use of parathyroid hormones or derivatives (Q107659)
  13. Injury or harm in therapeutic use by hydroxyquinoline derivatives (Q107658)
  14. Injury or harm in therapeutic use of dipyridamole (Q107657)
  15. Injury or harm in therapeutic use by nicotinic acid derivatives (Q107656)
  16. Injury or harm in therapeutic use of caffeine (Q107655)
  17. Injury or harm in therapeutic use of rauwolfia (Q107654)
  18. Injury or harm in therapeutic use of clonidine (Q107653)
  19. Injury or harm in therapeutic use of guanethidine (Q107652)
  20. Injury or harm in therapeutic use by carbamazepine (Q107651)
  21. Injury or harm in therapeutic use by amantadine (Q107650)
  22. Injury or harm in therapeutic use by antineoplastic antibiotics (Q107649)
  23. Injury or harm in therapeutic use by tamoxifen (Q107648)
  24. Injury or harm caused by tissue‐type plasminogen activator in therapeutic use (Q107647)
  25. Injury or harm in therapeutic use of thiobarbiturates (Q107646)
  26. Injury or harm in therapeutic use of acetylsalicylic acid (Q107645)
  27. Injury or harm in therapeutic use by cytarabine (Q107644)
  28. Ig beta deficiency (Q107643)
  29. Benign neoplasm of labia minora (Q107642)
  30. B-cell linker deficiency (Q107641)
  31. Lambda 5 deficiency (Q107640)
  32. Ig alpha deficiency (Q107639)
  33. Benign neoplasm of labia majora (Q107638)
  34. Absence of organ of Corti (Q107637)
  35. Swiss type autosomal recessive agammaglobulinaemia (Q107636)
  36. ESCOLA SUPERIOR DE CIÊNCIAS DA SANTA CASA DE MISERICORDIA DE VITÓRIA (Q107635)
  37. Benign neoplasm of uterine ligament (Q107634)
  38. (Q107633)
  39. (Q107632)
  40. Subependymoma of brain (Q107631)
  41. (Q107630)
  42. (Q107629)
  43. Myxopapillary ependymoma of brain (Q107628)
  44. Benign ependymoma (Q107627)
  45. Suffocation and strangulation due to pillow (Q107626)
  46. Protoplasmic astrocytoma of brain (Q107625)
  47. Gemistocytic astrocytoma of brain (Q107624)
  48. Pilomyxoid astrocytoma of brain (Q107623)
  49. Fibrillary astrocytoma of brain (Q107622)
  50. Peptic ulcer, unspecified as acute or chronic, with multiple complications (Q107621)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://determinar.ia.br/wiki/Special:ItemsWithoutSitelinks"